Genetron Holdings Limited - stock earnings
GTH Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q1 | -29.1 million USD | 29.3 million USD |
2022Q3 | -28.1 million USD | 28.3 million USD |
2022Q2 | -35.1 million USD | 20.6 million USD |
2022Q1 | -25.6 million USD | 23.1 million USD |
2021Q4 | -25.6 million USD | 23.1 million USD |
2021Q3 | -20.0 million USD | 23.7 million USD |
2021Q2 | -14.2 million USD | 21.8 million USD |
2021Q1 | -11.2 million USD | 20.4 million USD |
2020Q4 | -11.2 million USD | 20.5 million USD |
2020Q3 | -7.1 million USD | 16.5 million USD |
2020Q2 | -400.9 million USD | 14.4 million USD |
2020Q1 | -16.3 million USD | 10.8 million USD |
2019Q4 | -19.3 million USD | 14.8 million USD |
2019Q3 | -38.6 million USD | 11.4 million USD |
2019Q2 | -19.8 million USD | 10.6 million USD |
2019Q1 | -19.5 million USD | 9.9 million USD |
2018Q4 | -18.1 million USD | 10.8 million USD |
2018Q3 | -49.5 million USD | 22.0 million USD |
GTH Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | -128.3 million USD | 94.4 million USD |
2021 | -69.0 million USD | 83.7 million USD |
2020 | -30.3 million USD | 65.0 million USD |
2019 | -46.1 million USD | 46.3 million USD |
2018 | -67.7 million USD | 32.8 million USD |
2017 | -64.5 million USD | 15.5 million USD |
GTH
Price: $4.02
52 week price:
Earnings Per Share: -3.67 USD
P/E Ratio: -1.03
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 69849
Market Capitalization: 124.0 million